跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,587 条关于
“primary hyperparathyroidism”
全部
29,587
临床试验
18,598
药物
84
机构
33
资讯
10,872
2年前
Hong Kong Approves Two New Drugs for Hypercalcemia Under "1+" Mechanism
去年
Amgen Advances Phase 3 Study of Etelcalcetide for Pediatric Secondary Hyperparathyroidism
去年
AstraZeneca's Eneboparatide Meets Primary Endpoint in Phase III Trial for Hypoparathyroidism
去年
Alebund's AP301 Meets Primary Endpoint in Phase 3 Trial for Hyperphosphatemia in Dialysis Patients
去年
Relacorilant Fails to Meet Primary Endpoint in GRADIENT Trial for Cushing's Syndrome
2年前
RYBREVANT® Plus Lazertinib Shows Significant PFS Improvement in EGFR-Mutated NSCLC
2年前
Replimune's RP1 Shows Durable Responses in Anti-PD1 Failed Melanoma
去年
Barzolvolimab Achieves Primary and Secondary Endpoints in Phase 2 CIndU Trial
4个月前
Palopegteriparatide Shows Sustained 3-Year Benefits in Hypoparathyroidism Treatment
去年
UroMems' Smart Urinary Sphincter Implant Achieves Primary Endpoints in Pioneering Female SUI Study
第 1 页，共 1088 页
上一页
下一页
